Salifou Ouédraogo
Research Subjects
Research Interests
Salifou Ouédraogo has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Adama Diallo
National Tuberculosis Control Program, Ouagadougou P.O. Box 6632, Burkina Faso
1 shared publication - Adjima Combary
National Tuberculosis Control Program (PNT), Ouagadougou, Burkina Faso.
1 shared publication - Corinne Simone Merle
UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland
1 shared publication - Désiré Lucien Dahourou
MONOD Project, ANRS 12206, Centre de Recherche Internationale pour la Santé, Ouagadougou, Burkina Faso
1 shared publication - Isidore Tiandiogo Traoré
Nazi Boni University
1 shared publication - Vanessa Veronese
The Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, 1211 Geneva, Switzerland
1 shared publication
Latest Publications
- Open Access
- 9 September 2022
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 7 (9) , 237
Delays in TB Diagnosis and Treatment Initiation in Burkina Faso during the COVID-19 Pandemic
The COVID-19 pandemic has significantly disrupted TB services, particularly in low resource settings. In Burkina Faso, a cross-sectional ‘before and after’ study was conducted to assess the impact of COVID-19 on access to TB services. Data was collected in two phases (Phase 1: December 2017–March 2018, and 2: October–December 2020) to estimate and compare various patient and system delays among TB patients before and during COVID-19 and explore changes in treatment seeking behaviors and practices. 331 TB patients were recruited across the two phases. A significant increase in median time between first symptom and contact with TB service (45 days vs. 26 days; p < 0.01) and decrease in median time between first contact and diagnosis, and treatment initiation, respectively, during COVID-19 compared to before. Fewer patients reported using public health centers and more patients reporting using private facilities as the point of first contact following TB symptom onset during the COVID-19 period compared to before. These findings suggest that COVID-19 has created barriers to TB service access and health seeking among symptomatic individuals, yet also led to some efficiencies in TB diagnostic and treatment services. Our findings can be help target efforts along specific points of the TB patient pathway to minimize the overall disruption of COVID-19 and future public health emergencies on TB control in Burkina Faso.
- 9 September 2022
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 7 (9) , 237
Open AccessDelays in TB Diagnosis and Treatment Initiation in Burkina Faso during the COVID-19 Pandemic
The COVID-19 pandemic has significantly disrupted TB services, particularly in low resource settings. In Burkina Faso, a cross-sectional ‘before and after’ study was conducted to assess the impact of COVID-19 on access to TB services. Data was collected in two phases (Phase 1: December 2017–March 2018, and 2: October–December 2020) to estimate and compare various patient and system delays among TB patients before and during COVID-19 and explore changes in treatment seeking behaviors and practices. 331 TB patients were recruited across the two phases. A significant increase in median time between first symptom and contact with TB service (45 days vs. 26 days; p < 0.01) and decrease in median time between first contact and diagnosis, and treatment initiation, respectively, during COVID-19 compared to before. Fewer patients reported using public health centers and more patients reporting using private facilities as the point of first contact following TB symptom onset during the COVID-19 period compared to before. These findings suggest that COVID-19 has created barriers to TB service access and health seeking among symptomatic individuals, yet also led to some efficiencies in TB diagnostic and treatment services. Our findings can be help target efforts along specific points of the TB patient pathway to minimize the overall disruption of COVID-19 and future public health emergencies on TB control in Burkina Faso.